Medication info
Riseprel Plus Tablets

Riseprel Plus Tablets

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mg / 1 tabletCholecalciferol Concentrate Powder›56mg / 1 tablet
Manufacturer / importer
Hybeast Pharmaceuticals Co., Ltd.
Appearance
Light orange oval film-coated tablets
Packaging
4 tablets (4 tablets/PTP*1)
Approval status
Active

MFDS item code 201700623 · Approved 2017.02.06 · Insurance code 628800970

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Take 1 tablet orally once weekly. 2. Elderly patients: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in elderly patients (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment with creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine. For adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it while upright with an adequate amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce its absorption. This medicine should not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking the medicine. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., those over 70 years of age, patients in nursing homes, or patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a week's supply of vitamin D at 800 IU per day. If a patient forgets to take a dose on the scheduled day, take it on the day it is remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children: The safety and efficacy in children and growing adolescents have not been established.

Ingredients

Manufacturer
Hybeast Pharmaceuticals Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women; treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men.

How to take

Adult dose

1. Adults: Take 1 tablet orally once weekly. 2. Elderly patients: No dose adjustment is necessary because the bioavailability and pharmacokinetics of this medicine in elderly patients (60 years and older) are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30ml/min or higher. This medicine is contraindicated in patients with severe renal impairment with creatinine clearance below 30ml/min. Food interferes with the absorption of this medicine. For adequate absorption, take it as follows: Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it while upright with an adequate amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce its absorption. This medicine should not be chewed or sucked because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking the medicine. Patients with inadequate dietary calcium and vitamin D intake should take supplements. Patients at high risk of vitamin D deficiency (e.g., those over 70 years of age, patients in nursing homes, or patients with chronic diseases) may need additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine, taken once weekly, provides a week's supply of vitamin D at 800 IU per day. If a patient forgets to take a dose on the scheduled day, take it on the day it is remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children: The safety and efficacy in children and growing adolescents have not been established.

Precautions

This medication may irritate the upper gastrointestinal mucosa, potentially causing issues such as esophagitis or esophageal ulcers. It should be taken with a sufficient amount of water, and patients should not lie down for at least 30 minutes after taking the medication. If difficulties swallowing occur or symptoms such as pain behind the sternum or heartburn appear, discontinue use immediately and consult a physician. This medication should not be administered to patients with esophageal dysfunction or severe renal impairment. Additionally, patients with allergies to the ingredients of this medication or certain genetic metabolic disorders should also refrain from taking it. During treatment, it is advisable not to take this medication together with other drugs or foods containing calcium, magnesium, iron, etc., and to adhere strictly to the timing and method of administration. It is important to ensure adequate intake of calcium and vitamin D while taking this medication, and supplements should be taken according to a physician's instructions if necessary. This medication is used for the treatment of osteoporosis and may cause side effects such as dyspepsia, myalgia, arthralgia, headache, and skin rash. Serious side effects such as osteonecrosis of the jaw, severe esophageal damage, and liver function abnormalities may occur rarely, so caution is required. Women who are pregnant or breastfeeding should consult a physician about taking this medication and may need to stop taking the medication or discontinue breastfeeding if necessary. In case of overdose, symptoms of hypocalcemia may arise due to low serum calcium levels, and if symptoms are suspected, immediate medical attention is required. Keep this medication out of reach of children, and do not transfer it to another container.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • dysphagia
  • odynophagia
  • retrosternal pain
  • heartburn
Show 101 more
  • gastric ulcer
  • duodenal ulcer
  • osteoporosis
  • infection
  • low back pain
  • pain
  • abdominal pain
  • neck pain
  • weakness
  • chest pain
  • neoplasm
  • hernia
  • hypertension
  • cardiovascular disease
  • angina
  • nausea
  • diarrhea
  • bloating
  • gastritis
  • gastrointestinal disease
  • rectal disease
  • dental disease
  • purpura
  • anemia
  • arthralgia
  • joint abnormalities
  • myalgia
  • bone pain
  • bone abnormalities
  • leg cramps
  • bursitis
  • tendon abnormalities
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • hypertonia
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • itching
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • duodenitis
  • glossitis
  • abnormal laboratory test results
  • hypocalcemia
  • hypophosphatemia
  • fever
  • influenza-like symptoms
  • injuries from accidents
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reactions
  • syncope
  • vasodilation
  • constipation
  • dyspepsia
  • nausea
  • gastroenteritis
  • colitis
  • vomiting
  • polydipsia
  • peripheral edema
  • traumatic fractures
  • myopathy
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • facial edema
  • hair loss
  • altered smell
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • osteonecrosis of the jaw
  • liver dysfunction
  • jaundice
  • external auditory canal osteonecrosis
  • loss of appetite
  • discomfort in the chest
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air or moisture. It should be kept at room temperature, neither too high nor too low, ideally between 1°C and 30°C.

Appearance and packaging

Appearance

Light orange oval film-coated tablets

Package unit

4 tablets (4 tablets/PTP*1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.